Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026

Join Pharma | Login

	Editorial


	The Forced Swim Test
	Tuesday, May 6, 2025
	The animal rights organization, People for the Ethical Treatment of Animals (PETA) has recently sent a letter to the Pharmacy Council of India (PCI) for discontinuing the Forced Swim Test (FST) in thousands of
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026
17:50 [IST]	Amrita Vishwa Vidyapeetham wins C-CAMP GAMRIF AMR Challenge 2024–25
17:40 [IST]	Senores Pharmaceuticals appoints Gautam Shah as president of US operations
17:30 [IST]	TPG will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India
17:00 [IST]	NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine
16:45 [IST]	Breach Candy Hospital launches advanced modular operation theatres in collaboration with Dräger India

more news >>

TOP NEWS


08:00 [IST]	DTAB recommends all antimicrobials to be considered as new drug under NDCT Rules
08:00 [IST]	FDCA reports surge in number of licenses since roll out of mDMLA App: Dr H G Koshia
08:00 [IST]	DTAB recommends enabling legal provision on OTCs
08:00 [IST]	Delhi DCA conducts raids on wholesaler’s premises and seize counterfeit versions of Vertin tab worth Rs. 5 lakhs
08:00 [IST]	Pulmonologists alarmed by climate-linked asthma surge, find hope in novel medications
08:00 [IST]	SCDA again urges Centre to act against online sale of medicines

more news >>

YESTERDAY'S NEWS


18:00 [IST]	NIH researchers find many genes in male and female placentas expressed differently
17:00 [IST]	New gene-editing therapy shows early success in fighting advanced GI cancers
15:45 [IST]	Maharashtra government, in association with HLL, launch 103 new 'Aapla Dawakhana' clinics to provide free healthcare
13:45 [IST]	Akums' patented ‘Tablet-in-Tablet’ Technology Brings relief for expectant mothers
12:30 [IST]	Sri Adichunchanagiri College of Pharmacy’s Dr Robin George’s pilot study on SGLT2 inhibitor on heart failure management wins best oral presentation
12:15 [IST]	Biocon Biologics secures market access for Yesintek in the US driven by demand from national and commercial formularies

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore Methotrexate 2.5 Mg Tab/cap Fluvoxamine 100mg Tab Vitamin D3 Inj -600000 Iu-1 Ml. Tab Tianeptine 12.5 Mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers